VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,315,000 | -38.5% | 22,770 | +7.9% | 1.14% | -35.7% |
| Q3 2015 | $3,764,000 | -14.6% | 21,100 | +6.3% | 1.77% | +12.3% |
| Q2 2015 | $4,410,000 | +11.8% | 19,850 | 0.0% | 1.58% | +11.4% |
| Q1 2015 | $3,943,000 | +119.1% | 19,850 | +57.8% | 1.41% | +77.9% |
| Q4 2014 | $1,800,000 | +39.3% | 12,580 | +27.7% | 0.80% | +42.0% |
| Q3 2014 | $1,292,000 | -44.9% | 9,850 | -47.0% | 0.56% | -34.5% |
| Q2 2014 | $2,346,000 | -4.3% | 18,600 | 0.0% | 0.86% | -9.8% |
| Q1 2014 | $2,452,000 | +12.3% | 18,600 | 0.0% | 0.95% | +10.2% |
| Q4 2013 | $2,184,000 | -10.3% | 18,600 | -20.3% | 0.86% | -12.1% |
| Q3 2013 | $2,436,000 | +18.9% | 23,350 | -1.9% | 0.98% | +8.9% |
| Q2 2013 | $2,049,000 | – | 23,800 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |